Alexandra Riddell Selected Research

Myocardial Infarction

1/2022	Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.
1/2020	Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandra Riddell Research Topics

Disease

2	Hyperaldosteronism (Conn Syndrome) 10/2022 - 10/2021
2	Myocardial Infarction 01/2022 - 01/2020
1	Essential Hypertension 10/2022
1	Cushing Syndrome 10/2022
1	Paraganglioma (Paragangliomas) 10/2022
1	Pheochromocytoma 10/2022
1	Infarction (Infarctions) 01/2022
1	Reperfusion Injury 01/2022
1	Myocardial Reperfusion Injury 01/2022
1	Heart Failure 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Hypertrophy 01/2018

Drug/Important Bio-Agent (IBA)

2	MicroRNAs (MicroRNA)IBA 10/2022 - 10/2021
2	CalciumIBA 01/2022 - 01/2018
1	catechol (pyrocatechol)IBA 10/2022
1	SteroidsIBA 10/2022
1	(2S,3S)-oxirane-2,3-dicarboxylic acid 2- (((S)- 1- benzylcarbamoyl- 2- phenyl- ethyl)- amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Cathepsin LIBA 01/2022
1	Connexin 43 (Connexin43)IBA 01/2020

Therapy/Procedure

1	Percutaneous Coronary Intervention 01/2022